Results 101 to 110 of about 15,419 (219)
AIRP onlus partecipa al 1° Summit Europeo dedicato ai pazienti affetti da ADPKD
On Saturday the16th March 2019, AIRP participated at the 1st European ADPKD Patient Summit – a unique event designed to promote patient-centred care by providing an interactive forum for patients and experts to discuss ADPKD care, research and advocacy ...
Flavia Galletti, Franco Martini
doaj +1 more source
Revisiting racial differences in ESRD due to ADPKD in the United States
IntroductionAutosomal dominant polycystic kidney disease (ADPKD) affects all races. Whether the progression of ADPKD varies by race remains unclear.MethodsIn this retrospective cohort study from 2004 to 2013 non-Hispanic blacks and non-Hispanic whites of
E. Murphy +6 more
semanticscholar +1 more source
Canonical Wnt inhibitors ameliorate cystogenesis in a mouse ortholog of human ADPKD.
Autosomal dominant polycystic kidney disease (ADPKD) can be caused by mutations in the PKD1 or PKD2 genes. The PKD1 gene product is a Wnt cell-surface receptor. We previously showed that a lack of the PKD2 gene product, PC2, increases β-catenin signaling
Ao Li +11 more
semanticscholar +1 more source
Heterogeneous Cardiovascular Profiles in CKD: ADPKD Versus non-ADPKD
Au, Eric H.K., Gupta, Aditi
openaire +2 more sources
Profiling of miRNAs and target genes related to cystogenesis in ADPKD mouse models
Autosomal polycystic kidney disease (ADPKD) is a common inherited renal disease characterized by the development of numerous fluid-filled cysts in both kidneys.
Yu mi Woo +14 more
semanticscholar +1 more source
Overview of ADPKD in Pregnancy
Autosomal dominant polycystic kidney disease (ADPKD) is a systemic disorder that often affects patients in their third to fifth decades of life and is characterized by kidney cysts, chronic kidney disease (CKD), hypertension, and hepatic cysts. The development of clinical symptoms often coincides with childbearing years. Consequently, there are several
Ruth E. Campbell +2 more
openaire +3 more sources
Although translational research into autosomal dominant polycystic kidney disease (ADPKD) and its pathogenesis has made considerable progress, there is presently lack of standardized animal model for preclinical trials.
Ao Li +11 more
semanticscholar +1 more source
Phosphorylation, protein kinases and ADPKD
Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disease characterized by renal cyst formation and caused by mutations in the PKD1 and PKD2 genes, which encode polycystin-1(PC-1) and -2 (PC-2) proteins, respectively. PC-1 is a large plasma membrane receptor involved in the regulation of several biological functions and signaling ...
openaire +2 more sources
Miwa Kaneko, Tetsu Akimoto, Daisuke Nagata Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Tochigi, JapanCorrespondence: Tetsu Akimoto, Division of Nephrology, Department of Internal Medicine, Jichi Medical University ...
Kaneko M, Akimoto T, Nagata D
doaj
Background Autosomal dominant polycystic kidney disease (ADPKD) is the most prevalent hereditary kidney disease, characterized by enlarged kidneys with numerous cysts, high blood pressure, and a variety of extrarenal complications.
Sylvain Bodard +3 more
doaj +1 more source

